Establishing secure connection…Loading editor…Preparing document…

Drug Screening Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

DRUG SCREENING CONSENT AND SERVICE AGREEMENT

Effective Date:

PARTIES

Date of Birth:

Employer (if applicable):

RECITALS

WHEREAS, the Testing Provider is duly qualified and authorized to perform specimen collection and laboratory analysis for drugs and alcohol in accordance with applicable industry standards and the terms set forth herein; and

WHEREAS, the Individual/Applicant consents to provide specimens and to the performance of drug and/or alcohol testing as set forth in this Agreement, and authorizes release of test results as specified below; and

WHEREAS, the parties desire to set forth the scope of services, payment arrangements, confidentiality obligations and other terms governing the testing services to be provided by Testing Provider to the Individual/Applicant and, where applicable, to the Employer identified above.

CONSENT TO TESTING AND AUTHORIZATIONS

The Individual/Applicant hereby voluntarily consents to the collection of biological specimens (including, but not limited to, urine, saliva, blood, or hair) and to the performance of laboratory analysis for the presence of controlled substances, alcohol, or their metabolites. The Individual/Applicant further authorizes the Testing Provider and its agents to release test results, Medical Review Officer (MRO) determinations, and chain-of-custody documentation to the Employer, to the MRO retained by the Provider, and to any person or entity with a lawful need to know the results for employment, safety, or regulatory compliance purposes.

The Individual/Applicant understands that refusal to provide a specimen, tampering with a specimen, or otherwise failing to comply with collection procedures may be treated as a positive test or as non-compliance under applicable policies, and may have employment-related or other consequences.

I consent to drug testing (controlled substances).

I consent to alcohol testing.

I consent to reasonable random testing as required by Employer or program rules.

I authorize release of results to Employer and to medical or regulatory authorities as required by law.

SCOPE OF WORK

PAYMENT TERMS

The party responsible for payment shall be:

Late Payment Fee: (applies if payment is more than days overdue).

TESTING PROCEDURES, MRO REVIEW, AND RETESTS

All specimens will be collected in accordance with accepted chain-of-custody procedures. Positive or otherwise non-negative results will be reviewed by a certified Medical Review Officer (MRO) prior to reporting. The Individual/Applicant may request split-sample testing or confirmatory tests in accordance with the Provider's policies; any costs for split-sample testing requested by the Individual/Applicant shall be allocated as follows:

TERM AND TERMINATION

This Agreement shall commence on and shall continue until unless earlier terminated in accordance with this Section.

Either party may terminate this Agreement for convenience upon days' prior written notice. Termination for cause may be immediate for material breach, including but not limited to refusal to submit to testing or failure to pay undisputed fees.

CONFIDENTIALITY

Testing Provider shall maintain confidentiality of test results and related medical information, disclosing such information only to the Individual/Applicant, the Employer (if authorized by the Individual/Applicant or required by applicable law), the MRO, and other parties as permitted by law. Testing Provider shall implement reasonable administrative, physical, and technical safeguards to protect personally identifiable health information.

LIMITATION OF LIABILITY; INDEMNIFICATION

Each party's liability to the other for any claim arising out of this Agreement shall be limited to direct damages and shall exclude consequential, incidental, punitive or exemplary damages to the extent permitted by law. The Individual/Applicant agrees to indemnify and hold harmless the Testing Provider from claims arising from intentional misrepresentation, tampering, or fraudulent conduct by the Individual/Applicant.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the state of , without regard to conflict of law principles.

ENTIRE AGREEMENT

This Agreement constitutes the entire understanding between the parties with respect to the subject matter hereof and supersedes all prior agreements, negotiations, and understandings, whether written or oral. Any amendment or modification shall be in writing and signed by both parties.

ACKNOWLEDGMENT AND CERTIFICATION

By signing below, the Individual/Applicant certifies that all information provided in connection with this Agreement is true and accurate to the best of their knowledge, that they have been informed of the nature and purpose of the testing, and that they freely consent to the collection and testing of specimens as described herein.

Applicant Contact Information - Address:

Applicant Contact Information - Phone: Email:

Individual/Applicant:

By:

Date:

Testing Provider:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Drug Screening Consent Form Is and when it's used

A Drug Screening Consent Form documents an individual's informed agreement to provide biological samples for drug or alcohol testing and authorizes disclosure of test results to designated parties. Employers, clinics, and testing laboratories use it to show voluntary or conditional consent for pre-employment, reasonable suspicion, post-incident, random, or return-to-duty testing. The form typically explains testing methods, sample types, confidentiality protections, consequences of refusal or a positive result, and how results will be reported or retained. Proper documentation helps meet workplace safety, regulatory, and chain-of-custody requirements while protecting privacy rights.

Why a clear consent form matters for compliance and privacy

A well-drafted Drug Screening Consent Form reduces legal exposure by documenting informed consent, clarifying permitted uses of results, and supporting evidentiary chain-of-custody. It aligns with federal e-signature standards like the ESIGN Act (15 U.S.C. ch. 96) and state UETA laws for valid electronic execution.

Why a clear consent form matters for compliance and privacy

Who completes and relies on this form

Typical users include employers, HR teams, occupational health clinics, and laboratory service providers who need documented consent and release to process and share test results.

  • Employers and HR departments administering hiring or safety programs that require documented consent for testing and result disclosure.
  • Occupational health clinics and collection sites that must verify identity, obtain signatures, and preserve chain-of-custody documentation.
  • Laboratories and medical review officers (MROs) receiving authorization to report results to a named employer or third party.

All signers should receive a copy and retain a record for the applicable retention period; the form should also identify the individual authorized to receive results.

Core elements that a professional Drug Screening Consent Form should include

A compliant form clearly identifies parties, specifies sample types and test methods, explains privacy safeguards, sets result disclosure rules, and includes a dated signature block for the signer and a witness or collector when required.

Identification

Full legal name, date of birth, employee or applicant ID and contact details to ensure accurate linkage to test specimens and records.

Testing Scope

Specify sample type (urine, saliva, hair, blood), substances screened, and whether confirmatory testing will be used for presumptive positives.

Authorization

Explicit authorization for specimen collection, laboratory analysis, medical review, and release of results to named employers or agents.

Privacy Notice

Statement describing confidentiality protections, applicable laws (for example HIPAA where health records apply), and who will access test results.

Consequences

Clear explanation of disciplinary or employment actions tied to a positive result or refusal, including any drug-free workplace policies.

Signature Block

Dated signer signature, collector or witness signature where required, and a statement confirming voluntary or conditional consent.

Step-by-step: how to complete and process the form

Follow these sequential steps to obtain valid consent, collect specimens, and route results while preserving chain-of-custody.

  • 01
    Provide ID: Present government-issued photo ID for identity verification.
  • 02
    Review Information: Read the disclosure, sample types, and result uses before signing.
  • 03
    Sign Consent: Sign and date the consent in ink or electronically with compliant e-signature.
  • 04
    Collect Specimen: Collector documents chain-of-custody and forwards specimen to the laboratory.

Typical digital workflow settings for online completion and routing

Configure these fields in your e-signature or HR platform to ensure secure collection and correct routing of signed forms.

Field Configuration
Signer Authentication Email plus optional SMS code or ID check
Signature Type Adopt standard e-signature with audit trail
Result Recipient Pre-fill employer or MRO contact details
Retention Rule Automated retention per policy and legal basis

How electronic submission and result reporting typically flow

This sequence shows common handoffs when the consent form is completed and transmitted electronically.

  • Sign: Signer completes consent via mobile or desktop.
  • Collect: Collector or clinic records specimen details and COC.
  • Laboratory: Lab performs initial and confirmatory testing as needed.
  • Report: MRO or lab sends results to authorized recipient.

Technical considerations for eSigning and eSubmission

Use an e-signature platform that preserves an immutable audit trail, supports required authentication, and outputs legally reproducible records.

  • Audit Trail: Capture timestamp, IP, and signer actions.
  • Authentication: Support email, SMS, or ID verification.
  • Integrations: Connect to HRIS, EHR, or cloud storage.

Essential privacy and security elements to include

HIPAA Notice: Include privacy language
BAA Requirement: Use a BAA with vendors
Encryption: TLS in transit; AES-256 at rest
Access Controls: Role-based access only
Audit Logs: Preserve comprehensive audit trail
Retention Policy: Document retention schedule set

Common legal risks and penalties tied to defective consent forms

HIPAA Breach: Civil and enforcement exposure
Invalid Consent: Test results may be inadmissible
I-9 or DOT Issues: Regulatory noncompliance risks
Discrimination Claims: Potential employment litigation
Chain-of-Custody Gaps: Laboratory sample rejections
Recordkeeping Violations: Fines and audit findings

Timing considerations and typical deadlines for drug screening workflows

Adhere to testing windows and reporting timelines to preserve evidentiary value and meet program rules.

Pre-employment screening deadline:

Collect consent and specimen before start date when required

Specimen collection window:

Follow collection protocols promptly after incident or notification

Lab reporting time:

Labs typically report confirmed positives within 24–72 hours

Record retention start date:

Retention period begins on creation or last effective date

Revocation notice timeframe:

Document revocation immediately; clarify effect on pending tests

Best practices to reduce errors and legal exposure

Adopt consistent procedures and clear documentation to improve accuracy, protect privacy, and reduce disputes.

Use plain-language disclosure
Write consent statements in clear, non-technical language explaining what is tested, who receives results, and the consequences of refusal to avoid ambiguity and build informed consent.
Verify identity at collection
Require government-issued photo ID at collection and record the ID type and number if permitted; mismatches can invalidate results and increase dispute risk.
Preserve chain-of-custody
Ensure collectors complete chain-of-custody forms, seal specimens, and log transfers to avoid laboratory rejections and maintain evidentiary integrity.
Implement privacy safeguards
Limit access to results, use encrypted storage, and execute BAAs with vendors when health information is involved to comply with HIPAA and state privacy laws.

Realistic scenarios showing how the form is used

These short scenarios illustrate common use cases for Drug Screening Consent Forms in employment and safety-sensitive contexts.

Pre-employment Screening

A hiring manager requires consent before onboarding to verify applicant fitness for safety-sensitive work

  • The collector confirms identity and collects a urine specimen
  • The employer receives a signed consent and lab report, preserving chain-of-custody for compliance and personnel records.

Post-incident Testing

After a workplace incident, safety protocol triggers reasonable suspicion testing consistent with policy

  • The worker signs a consent acknowledging the purpose and recipient of results
  • The lab returns a confirmatory result to a designated MRO, and HR follows the documented disciplinary or return-to-duty procedures.

Desktop and cloud e-signature pricing snapshot (vendor columns for comparison)

Basic pricing and capability differences for typical e-signature providers. Use vendor sites for full plan details and enterprise features.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes (Business Premium) Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently asked questions and answers about the Drug Screening Consent Form

Answers to common questions about validity, identity verification, privacy, and handling disputes related to drug-screening consent.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.